Bcl-xL Modulates Apoptosis Induced by Anticancer Drugs and Delays DEVDase and DNA Fragmentation-Promoting Activities
- 10 April 1998
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 240 (1), 107-121
- https://doi.org/10.1006/excr.1998.4003
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Inhibition of Bax Channel-Forming Activity by Bcl-2Science, 1997
- Bcl-xL forms an ion channel in synthetic lipid membranesNature, 1997
- Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32.Journal of Clinical Investigation, 1996
- Apoptosis and chemotherapy resistanceEuropean Journal Of Cancer, 1996
- Bcl-2 Overexpression Blocks Activation of the Death Protease CPP32/Yama/ApopainBiochemical and Biophysical Research Communications, 1996
- Effect of Protease Inhibitors on Early Events of ApoptosisExperimental Cell Research, 1996
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overviewCancer and Metastasis Reviews, 1992
- Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cellsEuropean Journal Of Cancer, 1992
- Topoisomerase inhibitors induce irreversible fragmentation of replicated DNA in concanavalin A stimulated splenocytesBiochemistry, 1988